Selenium and the risk of cancer in BRCA1 carriers

Selenium and the risk of cancer in BRCA1 carriers

Bibliographic Details
Main Authors:	Lubinski J, Jaworska K, Durda K, Jakubowska A, Huzarski T, Byrski T, Stawicka M, Gronwald J, Górski B, Wasowicz W, Kilar E, Szwiec M, Surdyka D, Marczyk E, Sun P, Narod SA
Format:	Article
Language:	English
Published:	BMC 2011-06-01
Series:	Hereditary Cancer in Clinical Practice
Online Access:	http://www.hccpjournal.com/content/9/S2/A5

Similar Items

Selenium and genotypes as marker of risk in BRCA1 mutation carriers
by: Jaworska K, et al.
Published: (2012-01-01)

Prospective observation of breast/ovarian cancer risk in BRCA1 carriers depending on serum selenium level optimized with diet
by: Lubiński J, et al.
Published: (2012-01-01)

Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment
by: Byrski T, et al.
Published: (2012-04-01)

Cisplatin in breast cancer treatment in BRCA1 carriers
by: Gronwald Jacek, et al.
Published: (2012-12-01)

Folic acid and cancer risk in BRCA1 carriers
by: Durda Katarzyna, et al.
Published: (2012-04-01)

Impact of BRCA1 mutation on survival after early onset breast cancer
by: Huzarski T, et al.
Published: (2012-12-01)

A Lowering of Breast and Ovarian Cancer Risk in Women with a BRCA1 Mutation by Selenium Supplementation of Diet
by: Huzarski Tomasz, et al.
Published: (2006-01-01)

Vitamins A, E and D and cancer risk in BRCA1 carriers
by: Kąklewski K, et al.
Published: (2012-04-01)

Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
by: Byrski T, et al.
Published: (2011-06-01)

Why choose the treatment with cisplatin for BRCA1 breast cancers patients?
by: Byrski T, et al.
Published: (2012-01-01)

Ovarian cancer risk in Polish <it>BRCA1 </it>mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism
by: Benner Axel, et al.
Published: (2008-04-01)

Selenium (Se) and the risk of breast, ovarian and prostate cancers
by: Jaworska Katarzyna, et al.
Published: (2012-04-01)

Selenium and cancer risk in CHEK2 mutation carriers
by: Gupta Satish, et al.
Published: (2012-04-01)

Selenium (Se) and breast cancer risk
by: Jaworska - Bieniek Katarzyna, et al.
Published: (2012-12-01)

Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
by: Tomasz Kluz, et al.
Published: (2018-02-01)

Recurrent Mutations in <i>BRCA1</i>,<i> BRCA2</i>,<i> RAD51C</i>,<i> PALB2</i> and <i>CHEK2</i> in Polish Patients with Ovarian Cancer
by: Alicja Łukomska, et al.
Published: (2021-02-01)

Serum concentration of iron as predictor of cancer risk among BRCA1 mutation carriers
by: Sukiennicki Grzegorz, et al.
Published: (2012-04-01)

Identification of patients at high risk of negative psychological consequences associated with BRCA1 mutation
by: Ertmański S, et al.
Published: (2012-01-01)

Serum concentration of selected macro- and microelements and their correlation with the risk of breast and ovarian cancer among BRCA1 mutation carriers
by: Muszyńska Magdalena, et al.
Published: (2012-04-01)

Identification of new genes associated with breast and ovarian cancer risk. Advances of BCAC, CIMBA and OCAC
by: Jakubowska A, et al.
Published: (2011-06-01)

Serum Selenium Level Predicts 10-Year Survival after Breast Cancer
by: Marek Szwiec, et al.
Published: (2021-03-01)

The risk of breast cancer in women with a CHEK2 mutation
by: Cybulski Cezary, et al.
Published: (2012-01-01)

Selected aspects of genetic counselling for <it>BRCA1 </it>mutation carriers
by: Gronwald Jacek
Published: (2007-03-01)

CHEK2 mutations as markers for high risk of breast cancer
by: Cybulski Cezary, et al.
Published: (2012-04-01)

<it>BRCA1 </it>testing
by: Górski Bohdan, et al.
Published: (2008-06-01)

Blood Arsenic Levels as a Marker of Breast Cancer Risk among <i>BRCA1</i> Carriers
by: Wojciech Marciniak, et al.
Published: (2021-07-01)

Meeting abstracts from the Annual Conference on Hereditary Cancers 2016
by: C. Cybulski, et al.
Published: (2017-12-01)

Clinical Genetic Services for Familial Breast Cancer in Poland
by: J. Gronwald, et al.
Published: (1999-01-01)

Serum selenium level and cancer risk: a nested case-control study
by: Steven A. Narod, et al.
Published: (2019-12-01)

Selenium and the risk of cancer of the lung and larynx. A case-control study from a region with low selenium
by: Jaworska Katrzyna, et al.
Published: (2012-04-01)

BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update
by: Alena Savanevich, et al.
Published: (2021-01-01)

Zinc and breast cancer risk
by: Kaczmarek Katarzyna, et al.
Published: (2012-12-01)

Genetic predisposition to male breast cancer in Poland
by: Marek Szwiec, et al.
Published: (2021-08-01)

Rapid test for detection of high risk of breast cancer
by: Durda K, et al.
Published: (2012-01-01)

Coverage of the Genetic Background of Breast Cancer in the Polish Population
by: Serrano-Fernández Pablo, et al.
Published: (2006-11-01)

Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers
by: Stawicka Małgorzata, et al.
Published: (2008-04-01)

A low selenium level is associated with lung and laryngeal cancers.
by: Katrzyna Jaworska, et al.
Published: (2013-01-01)

Hormone Replacement Therapy Appears to Be Safe After Prophylactic Adnexectomy in Premenopausal BRCA1/BRCA2 Mutation Carriers. Reaction to the 'Letter to readers' in Hereditary Cancer in Clinical Practice, 2005, 3 (2)
by: Lubiński Jan
Published: (2005-09-01)

Management of the asymptomatic BRCA mutation carrier
by: Paige Teller, et al.
Published: (2010-11-01)

Correction: A Low Selenium Level Is Associated with Lung and Laryngeal Cancers
by: Katrzyna Jaworska, et al.
Published: (2013-01-01)